Table 2.
Neuroimaging characteristics of patients with COVID-19.
| Parenchymal Hemorrhage (n = 6) | |
| Location | |
| • Lobar, n (%) | 4 (66.7) |
| • Deep, n (%) | 1 (16.7) |
| • Infratentorial, n (%) | 1 (16.7) |
| Ventricular extension, n (%) | 1 (16.7) |
| SAH extension, n (%) | 1 (0) |
| Subarachnoid Hemorrhage (n = 11) | |
| Primary SAH, n (%) | 9 (81.8) |
| • Aneurysmal, n (%) | - |
| • Cortical, n (%) | 9 (81.8) |
| • Bilateral, n (%) | 4 (36.4) |
| • Ventricular extension, n (%) | - |
| Secondary SAH, n (%) | 2 (18.2) |
| Intraventricular Hemorrhage (n = 3) | |
| Isolated IVH | |
| • Supratentorial, n (%) | 3 (100) |
| • Infratentorial, n (%) | - |
| • SAH extension, n (%) | - |
| Secondary IVH *1, n (%) | 1 (33.3) |
| Subdural Hemorrhage (n = 1) | |
| Convexity, n (%) | 1 (100) |
| Bilateral, n (%) | - |
| SAH extension, n (%) | 1 (100) |
Legend: Comparison of neuroimaging characteristics in patients with COVID-19 and an acute intracranial hemorrhage. The distribution of imaging characteristics are presented in relation to their subsequent intracerebral hemorrhage type. SAH indicates subarachnoid hemorrhage. Please note: *1 = due to expansion in parenchymal hemorrhage.